tirzepatide zepbound Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Lilly launches lower-price weight-loss drug

In recent years, both drugs have been linked to gastrointestinal problems such as gastroparesis, or stomach paralysis, ileus and intestinal blockages

The design of clinical trials in hepatic encephalopathyan international society for hepatic encephalopathy and nitrogen metabolism (ISHEN) consensus statement

In a briefing document ahead of an advisory committee meeting, internal reviewers with the FDA flagged an excess risk of hypoglycemia in type 1 diabetes patients, which was not accompanied by evidence of any additional glycemic control or other benefit. Combining semaglutide with insulin icodec might help Novartis reinvigorate its GLP-1 blockbuster amid a formidable challenge by fellow obesity frontrunner Eli Lilly

Kojic Acid & Glutathione help fade discoloration, dark spots, and uneven skin tone

Sacituzumab Govitecan, a new antibody-drug conjugate, is one of the most recent advancements in this area and can potentially enhance outcomes for patients with metastatic triple-negative breast cancer